Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2014 · 10-Q
Revenue$16.37M$16.37M+11.7% vs Q2 2013 Net Income$886.00K$886.00K+743.8% vs Q2 2013 EPS Diluted$0.04$0.04— vs Q2 2013 Gross Profit$11,923,000+15.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,442,000+306.3% Free Cash Flowderived-$955,000N/M Margins · derivedGross margin72.8%+2.4 pt vs Q2 2013
Operating margin14.3%+8.4 pt vs Q2 2013
Net margin5.4%+4.7 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 1, 2014 · 32 d after period end